If you are a higher specialty trainee in rheumatology (typically ST4 and above) trying to decide whether you have done enough, this checklist is for you. "Covering" the SCE Rheumatology is not a completed question bank and it is not a percentage. It is a short set of things you can actually evidence. Before you tell yourself the syllabus is covered and stop doing new questions, you should be able to demonstrate four of them: measured coverage against every domain of the MRCP(UK) specialty certificate blueprint; deliberate practice in the formats the written papers really use; recency checks on the guidance-sensitive topics; and a readiness signal drawn from unseen, timed, mixed blocks rather than a headline score. The rest of this article turns each of those into something you can tick off, and gives you a stop/continue decision tree at the end.
The SCE Rheumatology at a glance
The Specialty Certificate Examination in Rheumatology is set by the Federation of the Royal Colleges of Physicians of the UK (the MRCP(UK) route) and is a certification requirement on the way to CCT. The structure is the standard SCE format shared across every physician specialty: two papers of 100 best-of-five (BOF) questions each, so 200 questions in total; each paper lasts three hours; both are sat on the same day; delivery is computer-based on the Surpass platform in an invigilated in-centre setting; there is one mark per correct answer and no negative marking. What is specialty-specific is the blueprint, which is derived from the JRCPTB rheumatology curriculum — not the mechanics of the paper.
Two features of that format should shape how you audit yourself. First, because there is no negative marking, leaving an item blank is never the right strategy; every question deserves an answer, and your working pace is roughly one item every 1.8 minutes with time left to review flags. Second, because it is a best-of-five paper, "I know this topic" is not the same as "I can pick the single best option out of five plausible ones under time pressure". A content-gap audit has to test the second thing, not the first. The single most common self-deception in SCE preparation is treating recall of a topic as evidence of exam-ready selection.
Build a blueprint coverage table
The authoritative reference is the MRCP(UK)/Federation SCE Rheumatology blueprint. Its published domain allocation (verified 21 July 2026; the source notes the actual number in any given diet "may vary slightly") is set out below, and it is the backbone of your audit. Do not audit yourself against a commercial bank's chapter list — audit against this.
| Blueprint domain | Official questions (of 200) | Questions attempted | First-attempt accuracy | Last reviewed | Confidence (R/A/G) |
|---|---|---|---|---|---|
| Adult inflammatory arthritis, incl. crystal arthropathies | 70 | ||||
| Adult connective tissue disorders | 60 | ||||
| Adult osteoarthritis / soft tissue / regional / widespread pain | 20 | ||||
| Adult infection, neoplasia and miscellaneous | 15 | ||||
| Adult metabolic and bone disease | 13 | ||||
| Paediatric and adolescent rheumatology | 12 | ||||
| Clinical science and pharmacology | 10 |
The blank columns are the point. Coverage is not "have I read this?" — it is "how many unseen items have I attempted in this domain, what was my first-attempt accuracy, when did I last review it, and how confident am I now?" Weight your remaining effort by official mark load: inflammatory arthritis and connective tissue disorders together account for 130 of 200 marks, so a two-mark wobble there matters far more than a gap in a 10-mark domain. But do not let the small domains fall to zero — paediatric and adolescent rheumatology is only 12 marks, yet it is the domain adult trainees most often skip entirely, and 12 marks can be the distance between a pass and a resit. This is the "completion is not coverage" principle applied to a real blueprint; if you want the general method, see the iatroX guide to building a blueprint-coverage matrix for any exam.
Ten domain-level blind spots self-selected practice tends to hide
Left to our own devices we practise what we already half-know and avoid what is uncomfortable. The following ten areas are where self-selected question practice most often leaves a hidden gap, and they are worth a specific check — ideally reviewed with a rheumatology-trained colleague who can confirm you have actually covered them rather than merely met them once.
- Axial spondyloarthritis imaging and classification — distinguishing radiographic from non-radiographic disease, reading MRI sacroiliitis, and applying ASAS criteria correctly rather than by pattern-matching.
- ANCA-associated vasculitis — separating GPA, EGPA and MPA, matching induction versus maintenance therapy, and applying the 2022 ACR/EULAR classification criteria.
- Systemic sclerosis complications — pulmonary hypertension screening, scleroderma renal crisis, and interstitial lung disease monitoring, not just cutaneous subtypes.
- Inflammatory myopathies — myositis-specific antibodies (anti-Jo-1/anti-synthetase, anti-MDA5, anti-TIF1γ) and the malignancy associations that change management.
- Paediatric and adolescent rheumatology — JIA subtypes and uveitis screening, juvenile dermatomyositis, macrophage activation syndrome, and transition; small mark load, frequently skipped.
- Crystal disease nuance — CPPD associations, urate-lowering targets, gout in renal impairment, and tophaceous management, beyond the acute attack.
- Metabolic bone disease — osteoporosis treatment sequencing, atypical femoral fracture and osteonecrosis of the jaw, Paget's, osteomalacia and hypophosphataemia.
- Biologic and DMARD safety — pre-treatment screening, vaccination rules, pregnancy and lactation compatibility, monitoring schedules and JAK-inhibitor cautions.
- Autoinflammatory and rarer systemic disease — periodic fever syndromes, adult-onset Still's disease, IgG4-related disease and amyloidosis.
- Overlap and mimics — sarcoid arthropathy, relapsing polychondritis, Behçet's, antiphospholipid syndrome in pregnancy, and paraneoplastic or drug-induced rheumatic syndromes.
If you cannot immediately say how many unseen items you have attempted in each of these — and what your accuracy was — that is your content gap, regardless of your overall percentage.
Format checklist: are you practising the right way?
The written paper does not just test facts; it tests applied selection across specific formats. Before you stop, verify that you have done deliberate, repeated practice in each:
- Imaging — plain radiographs (erosions, joint-space loss, chondrocalcinosis, sacroiliitis), MRI (bone-marrow oedema, synovitis), ultrasound (power-Doppler synovitis, the double-contour sign of urate) and DXA interpretation.
- Immunology — ANA patterns and titres, the ENA panel, ANCA (PR3/MPO), complement, rheumatoid factor and anti-CCP, HLA-B27, and synovial-fluid crystal analysis under polarised light.
- Classification criteria — knowing the ACR/EULAR and ASAS/SLICC criteria and, just as importantly, their limits (classification is not diagnosis).
- Biologic and drug monitoring — pre-treatment screening, monitoring schedules and the management of the patient over time, not just first-line choice.
Interpretation checklist
Rheumatology BOF items lean heavily on data interpretation. Tick each of these as a format you have deliberately drilled: radiographs and cross-sectional imaging; laboratory trends over time (inflammatory markers, renal function on treatment, urate, complement); simple calculations (FRAX inputs, creatinine clearance affecting drug choice, corticosteroid equivalence); and the professional and ethical items that appear across physician SCEs (consent, capacity, confidentiality, and evidence appraisal such as reading a study's confidence intervals). There is no ECG-heavy component, but do not assume a laboratory-trend or imaging vignette is "general medicine" and skip it — those are exactly where marks leak.
Recency checklist
Rheumatology is guidance-sensitive, and a bank written two years ago may be quietly out of date. For every guidance-linked topic, record the date and jurisdiction of the source you are trusting. Priority areas to re-verify against current UK sources (NICE, CKS, the British Society for Rheumatology guidelines, and the SmPC/eMC for medicines information) include: urate-lowering targets and treat-to-target gout management; osteoporosis treatment thresholds and drug-holiday timing; biologic and targeted-synthetic DMARD safety, including JAK-inhibitor cardiovascular and venous-thromboembolism cautions; hydroxychloroquine retinopathy screening; pre-biologic infection screening; and vaccination in the immunosuppressed. If your only source for a monitoring interval is a revision bank explanation, upgrade it to the SmPC or the relevant society guideline and note the date you checked.
Performance checklist: the readiness signal
Coverage and format are necessary but not sufficient. The readiness signal comes from performance under exam-like conditions. Before you stop, confirm all of the following: you have completed at least two unseen, timed, mixed-domain blocks that sample the whole blueprint (not single-topic sets); your pace holds at around one item per 1.8 minutes without a late-paper collapse; your high-confidence error rate — items you were sure of but got wrong — is low and falling, because these are the dangerous ones; your retention is durable, evidenced by spaced re-tests of previously missed items rather than immediate re-reads; and you have calibrated against genuinely official material at least once. Your overall bank percentage is not on this list on purpose — it is the least informative number you own. For why, see Your Q-Bank Percentage Is Not Your Exam Score.
The stop / continue decision tree
Use the measured gap, not the calendar or how tired you are, to choose the next activity:
- Continue new questions if any high-weight domain (inflammatory arthritis, connective tissue disease) is below your target first-attempt accuracy or has thin attempt volume. New unseen items are the only thing that fixes a coverage gap.
- Consolidate (stop new questions, review and re-test misses) if coverage is adequate everywhere but your high-confidence error rate is stubborn or retention is slipping. More novelty will not help; spaced retrieval of your own errors will.
- Simulate (full-length timed mixed papers) if content is solid but your pacing or stamina across a three-hour paper is untested.
- Seek teaching (a colleague, a regional course, an examiner-style walk-through) if the same reasoning error recurs across a domain — that is a mental-model problem a bank cannot repair.
- Rest if all signals are green and further cramming would only erode sleep. Diminishing returns are real, and fatigue converts safe knowledge into careless errors.
One-page checklist and a worked example
Copy this and complete it — it is your stop/go sheet:
- Blueprint table filled for all seven domains (attempts, first-attempt accuracy, last reviewed, confidence)
- No high-weight domain below target accuracy; no domain at zero attempts
- Imaging, immunology, classification and drug-monitoring formats each drilled deliberately
- Guidance-sensitive topics re-verified against a dated UK source
- ≥2 unseen, timed, mixed blocks completed; pace and stamina holding
- High-confidence error rate low and falling; misses re-tested after a spacing gap
- Calibrated against official material at least once
Worked example (illustrative, invented data). Priya, an ST5, has "finished" her main bank at 78% overall and feels done. Her blueprint table tells a different story. Inflammatory arthritis: 240 attempts, 82% first-attempt — green. Connective tissue disease: 190 attempts, 71% — amber, dragged down by vasculitis and myositis items. Metabolic bone disease: 30 attempts, 60% — red. Paediatric rheumatology: 6 attempts — effectively unassessed. Her high-confidence error rate is 14%, concentrated in drug-monitoring items she "knew". Read against the checklist, Priya has not covered the SCE; her 78% is hiding two red domains and a dangerous high-confidence error pattern. Her next actions are clear: continue new questions in connective tissue disease and bone disease, drill drug-monitoring format specifically, and add paediatric items — not "revise everything again". The number that felt reassuring was the least useful thing she owned.
Bottom line
You have covered the SCE Rheumatology when you can evidence it: a completed blueprint table with no red high-weight domains and no zero-attempt domain; deliberate format practice; dated recency checks; and a readiness signal from unseen, timed, mixed blocks with a low high-confidence error rate. Everything else — including your overall percentage and a bank's completion bar — is decoration. iatroX is not a rheumatology-specific SCE bank, and it does not pretend to be; specialist banks such as StudyPRN and the British Society for Rheumatology's own material carry the deep subspecialty content. What iatroX adds is the cross-specialty UK knowledge layer, spaced retrieval of your errors, and — most usefully here — a supply of unseen items to run the timed, mixed blocks that produce a trustworthy readiness signal rather than a rehearsed one.
FAQ
How do I know whether I have covered the full SCE Rheumatology blueprint? You know when your blueprint coverage table is complete for all seven official domains, with a meaningful number of unseen attempts and an acceptable first-attempt accuracy in each — not when a bank shows 100% completion. Anchor the table to the MRCP(UK)/Federation blueprint weightings (70/60/20/15/13/12/10 of 200) rather than a commercial chapter list, and treat any high-weight domain below target, or any domain with almost no attempts, as an uncovered gap regardless of your overall percentage.
Can one question bank be enough for SCE Rheumatology? For most candidates, no. A single bank gives you one author team's interpretation of the blueprint, one house style of distractor, and a fixed pool that becomes recognition once you have seen it twice; it cannot supply an unseen readiness signal after you have exhausted it. A specialist rheumatology bank is a reasonable primary resource, but you should pair it with genuinely official material for calibration and a separate source of unseen items for timed mixed blocks — the logic set out in the iatroX two-Q-bank rule.
What should I measure instead of my overall Q-bank percentage for SCE Rheumatology? Measure per-domain first-attempt accuracy on unseen items, weighted by the blueprint's mark load; your high-confidence error rate; your pacing and stamina across a full three-hour paper; and your retention of previously missed items after a spacing interval. These four tell you what a single blended percentage cannot: where the gap is, whether it is dangerous, and whether it is closing.
When should I stop doing new SCE Rheumatology questions? Stop when new questions stop changing your decisions — that is, when every high-weight domain is at target accuracy, no domain is unassessed, your recency checks are done, and two or more unseen timed mixed blocks confirm stable performance. At that point the right move is usually to consolidate and simulate, not to keep chasing novelty; more new items past this point mainly erode sleep for a marginal return.
Which SCE Rheumatology resource should I use for my weakest component? Match the resource to the deficit rather than to novelty. If the gap is subspecialty knowledge (say, vasculitis or myositis), a specialist rheumatology bank plus the relevant British Society for Rheumatology guideline is the right tool. If it is image or data interpretation, you need deliberate practice on real images with clinician feedback, not more stems. If it is an unseen-readiness gap, use a separate bank — including iatroX's cross-specialty items — to run fresh timed blocks so you are measuring transfer, not memory.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 21 July 2026. Exam-format facts are drawn from the Federation of the Royal Colleges of Physicians of the UK; the blueprint domain figures are quoted from the published MRCP(UK)/Federation SCE Rheumatology blueprint, which notes the actual number per diet may vary slightly. Any vendor figures cited elsewhere in this series are vendor-reported and should be re-verified on the product page. Disclosure: iatroX operates a UK question bank and clinical-knowledge platform; it is not a rheumatology-specific SCE bank, and its role here is confined to the cross-specialty knowledge, spaced-retrieval and unseen-measurement layer that a specialty bank does not claim to provide. Corrections are welcome via the feedback route on iatrox.com. References: the Federation SCE Rheumatology page and the SCE Rheumatology blueprint (thefederation.uk); the JRCPTB rheumatology curriculum; the British Society for Rheumatology guidelines (rheumatology.org.uk); and, internally, the iatroX articles on Q-bank percentage and blueprint-coverage mapping, plus the iatroX comparison hub.